You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MPS II

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mucopolysaccharidosis II Trial in Cincinnati (DNL310)

Enrolling by invitation
  • Mucopolysaccharidosis II
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Oct 10, 2023

MPS II Immunophenotyping

Recruiting
  • MPS II
  • +2 more
    • Durham, North Carolina
      Duke University
    Jun 3, 2022

    Mucopolysaccharidosis Type II (MPS II) Trial in Oakland, Montréal (RGX-121)

    Recruiting
    • Mucopolysaccharidosis Type II (MPS II)
    • RGX-121
    • Oakland, California
    • +1 more
    Oct 6, 2022

    Mucopolysaccharidosis Type II (MPS II) Trial in Brazil, United States (RGX-121)

    Recruiting
    • Mucopolysaccharidosis Type II (MPS II)
    • RGX-121
    • Oakland, California
    • +4 more
    Dec 22, 2022

    Mucopolysaccharidosis (MPS), Hunter Syndrome Trial (ELAPRASE, Rituximab, Methotrexate)

    Not yet recruiting
    • Mucopolysaccharidosis (MPS)
    • Hunter Syndrome
    • (no location specified)
    Aug 8, 2022

    Mucopolysaccharidosis II, MPS II Trial in United States (SB-913)

    Terminated
    Has Results
    • Mucopolysaccharidosis II
    • MPS II
    • SB-913
    • Oakland, California
    • +4 more
    Oct 21, 2022

    Mucopolysaccharidosis II Trial in Salt Lake City, Fairfax (Genetic HMI-203)

    Recruiting
    • Mucopolysaccharidosis II
    • Genetic HMI-203
    • Oakland, California
    • +5 more
    Jan 26, 2023

    Mucopolysaccharidosis Type II Observational

    Withdrawn
    • Mucopolysaccharidosis II
    • Observational
    • Oakland, California
    • +2 more
    Oct 6, 2022

    Hunter Syndrome Trial in Lexington

    Recruiting
    • Hunter Syndrome
      • Lexington, Massachusetts
        Shire
      Nov 7, 2022

      MPS I, MPS II, MPS IVA Trial in San Francisco (Aldurazyme (laronidase))

      Recruiting
      • MPS I
      • +8 more
      • Aldurazyme (laronidase)
      • San Francisco, California
        University of California
      Apr 21, 2022

      MPS IIIA, Sanfilippo Syndrome, Sanfilippo A Trial in Pittsburgh, North Adelaide, Santiago De Compostela (ABO-102)

      Terminated
      • MPS IIIA
      • +3 more
      • Pittsburgh, Pennsylvania
      • +2 more
      Jan 11, 2023

      MPS (RaDiCo Cohort) (RaDiCo-MPS)

      Recruiting
      • Mucopolysaccharidosis I
      • +7 more
        • Angers, France
        • +22 more
        Sep 12, 2023

        Mucopolysaccharidosis Type I (MPS I), Hurler Syndrome, Hurler-Scheie Syndrome Trial in Orange, Philadelphia, Porto Alegre

        Active, not recruiting
        • Mucopolysaccharidosis Type I (MPS I)
        • +2 more
        • RGX-111
        • Orange, California
        • +3 more
        Jan 9, 2023

        Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis VI Trial in Torrance (Adalimumab Injection [Humira],

        Recruiting
        • Mucopolysaccharidosis I
        • +2 more
        • Adalimumab Injection [Humira]
        • Saline Solution for Injection
        • Torrance, California
          The Lundquist Institute at Harbor-UCLA Medical Center
        Aug 9, 2022

        Mucopolysaccharidosis II, Hunter Syndrome Trial in Pusan, Seoul (GC1123)

        Not yet recruiting
        • Mucopolysaccharidosis II
        • Hunter Syndrome
        • GC1123
        • Pusan, Korea, Republic of
        • +2 more
        Jun 16, 2022

        MPS IIIA, Sanfilippo Syndrome, Sanfilippo A Trial in Australia, Spain, United States (ABO-102)

        Active, not recruiting
        • MPS IIIA
        • +3 more
        • ABO-102
        • Columbus, Ohio
        • +4 more
        Nov 8, 2022

        Neurodevelopmental Status in Pediatric Hunter Syndrome (MPS II)

        Completed
        • Mucopolysaccharidosis (MPS)
        • Hunter Syndrome
          • Oakland, California
          • +6 more
          Mar 15, 2021

          Mucopolysaccharidosis II Trial in Worldwide (Iduronate-2-sulfatase enzyme replacement therapy, iduronate-2-sulfatase enzyme

          Completed
          Has Results
          • Mucopolysaccharidosis II
          • Iduronate-2-sulfatase enzyme replacement therapy
          • +2 more
          • Oakland, California
          • +8 more
          May 30, 2021

          Mucopolysaccharidosis Type 3 B Trial in Worldwide (rAAV9.CMV.hNAGLU)

          Terminated
          • Mucopolysaccharidosis Type 3 B
          • rAAV9.CMV.hNAGLU
          • Columbus, Ohio
          • +3 more
          Apr 29, 2022

          The Natural History of Metachromatic Leukodystrophy

          Recruiting
          • MLD
          • +26 more
          • Palliative Care
          • Hematopoetic Stem Cell Transplantation
          • Pittsburgh, Pennsylvania
            The Program for the Study of Neurodevelopment in Rare Disorders,
          Nov 2, 2021

          Myozyme® and of Aldurazyme® in Male and Female Participants of

          Recruiting
          • Pompe Disease
          • Mucopolysaccharidosis Type I (MPS I)
            • Italy, Italy
              Investigational site Italy
            May 3, 2022

            Hunter Syndrome, Mucopolysaccharidosis II, MPS II Trial in Porto Alegre, Warsaw, Taipei (Idursulfase)

            Completed
            Has Results
            • Hunter Syndrome
            • +2 more
            • Idursulfase
            • Porto Alegre, RS, Brazil
            • +2 more
            May 14, 2021

            Mucopolysaccharidosis Type VI Trial in Naples, Ankara (AAV2/8.TBG.hARSB)

            Active, not recruiting
            • Mucopolysaccharidosis Type VI
            • AAV2/8.TBG.hARSB
            • Naples, Italy
            • +1 more
            Nov 22, 2021

            Mucopolysaccharidosis I, II, and VI Screening inHigh-Risk

            Terminated
            • Mucopolysaccharidosis (MPS)
              • Los Angeles, California
              • +13 more
              Mar 16, 2021

              Mucopolysaccharidosis II Trial in Netherlands, United States (DNL310)

              Recruiting
              • Mucopolysaccharidosis II
              • Oakland, California
              • +4 more
              Nov 14, 2022